tiprankstipranks
Trending News
More News >
Theravance Biopharma (TBPH)
:TBPH
US Market

Theravance Biopharma (TBPH) Cash flow

Compare
345 Followers

Theravance Biopharma Cash Flow

TBPH's free cash flow for Q3 2025 was $-6.51M. For the 2025 fiscal year, TBPH's free cash flow was decreased by $17.62M and operating cash flow was $-6.51M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -11.54M$ -27.00M$ -186.99M$ -207.86M$ -250.40M
Investing Cash Flow
$ 12.28M$ -32.70M$ 1.15B$ 124.49M$ 10.72M
Financing Cash Flow
$ -2.50M$ -198.93M$ -758.81M$ 91.86M$ 263.08M
End Cash Position
$ 38.63M$ 40.38M$ 299.01M$ 90.80M$ 82.30M
Free Cash Flow
$ -11.87M$ -29.48M$ -187.56M$ -211.26M$ -257.02M
Currency in USD

Theravance Biopharma Cash Flow